reduction of hyperprolactinemia by methysergide ( 4.4 mg p.o . ) and bromocriptine ( 2.5 ng p.o . ) was studied in 20 patients ( 7 subjects with pituitary macroadenoma and 13 hyperprolactinemic patients with normal sella turcica ) .
C0020514
hyperprolactinemia
C0006230
bromocriptine